NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/04/2024
Back to search
Official data from USPTO
OXY GENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
05/04/2024
Trademark type
Combined
Nice classes
40, 42
Filing date
01/15/2020
Registration date
11/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/16/2021
Last transaction
11/16/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
B-6041 Gosselies, BE
Examiner
BARAHONA, BYRON
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "OXY". The "O" and "X" are in blue, and the "Y" is in blue and purple. Below this wording is the stylized wording "GENE". The "G" is in blue and purple, the "E" is in blue, purple, and orange, and the "N" and "E" are in orange. There is a stylized blue, purple, red, and orange incomplete, wavy circle to the left of the wording that extends towards the right. The color white represents background and is not claimed as a part of the mark.
Holders and representatives
Holders
HENOGEN
N. P. (pessoa física)
Representatives
Monte L. Falcoff/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Supply in the nature of custom manufacture of production units for biological moleculesparticularly viral vectors and monoclonal antibodiesin the pharmaceutical and biopharmaceutical field; contract manufacturing for others of biological moleculesparticularly viral vectors and monoclonal antibodiesin the pharmaceutical and biopharmaceutical field; production in the nature of custom manufacture of biological moleculesparticularly viral vectors and monoclonal antibodiesin the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents
Class 42
Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological moleculesparticularly viral vectors and monoclonal antibodiesin the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents
Publications
History of USPTO decisions and trademark events.
53 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/03/2022
FIMP
FINAL DISPOSITION PROCESSED
05/03/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/31/2021
PUBO
PUBLISHED FOR OPPOSITION
08/31/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/29/2021
DOCK
ASSIGNED TO EXAMINER
08/23/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2021
EXPT
EXPARTE APPEAL TERMINATED
07/25/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
07/23/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/23/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
07/23/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/13/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2021
ALIE
ASSIGNED TO LIE
07/09/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/25/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/10/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/09/2021
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
04/06/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/03/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/05/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/26/2021
GNSL
LETTER OF SUSPENSION E-MAILED
01/26/2021
CNSL
SUSPENSION LETTER WRITTEN
01/26/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/19/2021
EXPI
EX PARTE APPEAL-INSTITUTED
01/19/2021
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
01/19/2021
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
01/19/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/26/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/26/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/26/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/20/2020
GNFR
FINAL REFUSAL E-MAILED
07/20/2020
CNFR
FINAL REFUSAL WRITTEN
07/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2020
RFNT
REFUSAL PROCESSED BY IB
05/15/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/28/2020
RFRR
REFUSAL PROCESSED BY MPU
04/28/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/11/2020
CNRT
NON-FINAL ACTION WRITTEN
04/10/2020
DOCK
ASSIGNED TO EXAMINER
04/01/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/12/2020
Continuous trademark protection
Get notified about every new filing that threatens OXY GENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.